(CW) Curtiss-Wright - Overview
Stock: Actuators, Valves, Pumps, Electronics, Subsystems
| Risk 5d forecast | |
|---|---|
| Volatility | 37.0% |
| Relative Tail Risk | -4.70% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.29 |
| Alpha | 102.59 |
| Character TTM | |
|---|---|
| Beta | 1.043 |
| Beta Downside | 0.946 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.21% |
| CAGR/Max DD | 2.17 |
EPS (Earnings per Share)
Revenue
Description: CW Curtiss-Wright February 13, 2026
Curtiss-Wright Corp. (NYSE:CW) designs, manufactures and services engineered products for aerospace & defense, commercial power, process and industrial markets through three operating segments: Aerospace & Industrial, Defense Electronics, and Naval & Power. The Aerospace & Industrial segment delivers power-management electronics, traction inverters, vehicle controls and surface-technology services; Defense Electronics supplies embedded computing modules, flight-test instrumentation and tactical communications; Naval & Power provides coolant pumps, compact motors, generators, severe-service valves and nuclear-reactor components, plus ship-repair services for the U.S. Navy.
In FY 2023 the company reported total revenue of **$2.2 billion**, with the Aerospace & Industrial segment contributing roughly **38 %** and Defense Electronics about **34 %** (Form 10-K). As of Q2 2024, operating margin stood at **7.5 %**, down 0.8 ppt year-over-year, reflecting higher raw-material costs. The order backlog was **$2.5 billion**, indicating roughly 1.1 × annual revenue of booked work, but the backlog is weighted toward defense contracts that are sensitive to federal budget cycles. On the macro side, U.S. defense spending is projected to rise **~5 % YoY** in FY 2025 (Congressional Budget Office), while commercial aerospace demand is expected to grow **~3 % CAGR** through 2028 (IATA). Both trends underpin demand for CW’s high-reliability components, yet the company remains exposed to cyclical aerospace capacity utilization and potential defense-budget reallocations.
Key risks include supply-chain volatility for specialty alloys, the concentration of naval-power revenue in U.S. government contracts, and the transition risk from legacy legacy propulsion systems to electric-drive technologies. Assuming current defense-budget trajectories and a modest recovery in commercial aircraft deliveries, a base-case earnings-per-share projection for FY 2025 is **$0.92 ± 0.12**, implying a price-to-earnings multiple near **12×** given the current market price of $11.50. However, a 10 % downward revision in defense spending would cut FY 2025 EPS by roughly **$0.07**, highlighting the sensitivity of the valuation to fiscal-policy shifts.
For a deeper quantitative assessment, you might explore ValueRay’s detailed valuation models for CW.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 484.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 0.91 > 1.0 |
| NWC/Revenue: 17.52% < 20% (prev 24.15%; Δ -6.63% < -1%) |
| CFO/TA 0.18 > 3% & CFO 934.1m > Net Income 484.2m |
| Net Debt (943.5m) to EBITDA (750.9m): 1.26 < 3 |
| Current Ratio: 1.44 > 1.5 & < 3 |
| Outstanding Shares: last quarter (37.2m) vs 12m ago -3.13% < -2% |
| Gross Margin: 37.20% > 18% (prev 0.37%; Δ 3683 % > 0.5%) |
| Asset Turnover: 68.55% > 50% (prev 62.60%; Δ 5.95% > 0%) |
| Interest Coverage Ratio: 10.99 > 6 (EBITDA TTM 750.9m / Interest Expense TTM 43.1m) |
Altman Z'' 5.72
| A: 0.12 (Total Current Assets 2.02b - Total Current Liabilities 1.41b) / Total Assets 5.22b |
| B: 0.83 (Retained Earnings 4.31b / Total Assets 5.22b) |
| C: 0.09 (EBIT TTM 474.2m / Avg Total Assets 5.10b) |
| D: 1.56 (Book Value of Equity 4.19b / Total Liabilities 2.69b) |
| Altman-Z'' Score: 5.72 = AAA |
Beneish M -3.07
| DSRI: 1.00 (Receivables 932.3m/835.0m, Revenue 3.50b/3.12b) |
| GMI: 0.99 (GM 37.20% / 36.96%) |
| AQI: 0.95 (AQ_t 0.50 / AQ_t-1 0.53) |
| SGI: 1.12 (Revenue 3.50b / 3.12b) |
| TATA: -0.09 (NI 484.2m - CFO 934.1m) / TA 5.22b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of CW shares?
Over the past week, the price has changed by +4.69%, over one month by +8.01%, over three months by +28.27% and over the past year by +109.78%.
Is CW a buy, sell or hold?
- StrongBuy: 5
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 711.4 | 1.3% |
| Analysts Target Price | 711.4 | 1.3% |
CW Fundamental Data Overview February 18, 2026
P/E Forward = 28.4091
P/S = 7.2509
P/B = 9.957
P/EG = 2.71
Revenue TTM = 3.50b USD
EBIT TTM = 474.2m USD
EBITDA TTM = 750.9m USD
Long Term Debt = 757.9m USD (from longTermDebt, last quarter)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 1.31b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 943.5m USD (from netDebt column, last quarter)
Enterprise Value = 26.31b USD (25.37b + Debt 1.31b - CCE 371.3m)
Interest Coverage Ratio = 10.99 (Ebit TTM 474.2m / Interest Expense TTM 43.1m)
EV/FCF = 47.52x (Enterprise Value 26.31b / FCF TTM 553.7m)
FCF Yield = 2.10% (FCF TTM 553.7m / Enterprise Value 26.31b)
FCF Margin = 15.83% (FCF TTM 553.7m / Revenue TTM 3.50b)
Net Margin = 13.84% (Net Income TTM 484.2m / Revenue TTM 3.50b)
Gross Margin = 37.20% ((Revenue TTM 3.50b - Cost of Revenue TTM 2.20b) / Revenue TTM)
Gross Margin QoQ = 37.53% (prev 37.68%)
Tobins Q-Ratio = 5.04 (Enterprise Value 26.31b / Total Assets 5.22b)
Interest Expense / Debt = 0.91% (Interest Expense 12.0m / Debt 1.31b)
Taxrate = 22.60% (40.0m / 177.0m)
NOPAT = 367.0m (EBIT 474.2m * (1 - 22.60%))
Current Ratio = 1.44 (Total Current Assets 2.02b / Total Current Liabilities 1.41b)
Debt / Equity = 0.52 (Debt 1.31b / totalStockholderEquity, last quarter 2.53b)
Debt / EBITDA = 1.26 (Net Debt 943.5m / EBITDA 750.9m)
Debt / FCF = 1.70 (Net Debt 943.5m / FCF TTM 553.7m)
Total Stockholder Equity = 2.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.49% (Net Income 484.2m / Total Assets 5.22b)
RoE = 18.74% (Net Income TTM 484.2m / Total Stockholder Equity 2.58b)
RoCE = 14.19% (EBIT 474.2m / Capital Employed (Equity 2.58b + L.T.Debt 757.9m))
RoIC = 10.35% (NOPAT 367.0m / Invested Capital 3.54b)
WACC = 9.31% (E(25.37b)/V(26.68b) * Re(9.76%) + D(1.31b)/V(26.68b) * Rd(0.91%) * (1-Tc(0.23)))
Discount Rate = 9.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.75%
[DCF Debug] Terminal Value 76.32% ; FCFF base≈525.5m ; Y1≈617.4m ; Y5≈939.7m
Fair Price DCF = 317.7 (EV 12.66b - Net Debt 943.5m = Equity 11.71b / Shares 36.9m; r=9.31% [WACC]; 5y FCF grow 18.63% → 2.90% )
EPS Correlation: 75.37 | EPS CAGR: 32.75% | SUE: 1.01 | # QB: 12
Revenue Correlation: 92.74 | Revenue CAGR: 15.07% | SUE: 2.77 | # QB: 1
EPS next Quarter (2026-03-31): EPS=3.26 | Chg30d=+0.273 | Revisions Net=+3 | Analysts=8
EPS current Year (2026-12-31): EPS=15.02 | Chg30d=+0.386 | Revisions Net=+5 | Growth EPS=+13.5% | Growth Revenue=+7.2%
EPS next Year (2027-12-31): EPS=16.68 | Chg30d=+0.340 | Revisions Net=+5 | Growth EPS=+11.1% | Growth Revenue=+7.9%